Approved Formulary
Add Formweb to your mobile device
Approved Formulary
HIGH ALERT: Please read the COMMENTS very carefully.
Do Not Crush Do not crush lozenge/lollipop - delivery system requires slow dissolution in mouth. Buccal tablets are to be swallowed whole.
Black Box Warning: Buccal tablets, nasal spray, and lozenges are only for management of breakthrough pain in opioid-tolerant patients.
Search results for:
FENTANYL
FENTANYL
| Drug Name | Form | Strength | Non-Formulary | Notes |
|---|---|---|---|---|
| FENTORA | BUCCAL | 100 MCG | ||
| FENTORA | BUCCAL | 200 MCG | ||
| FENTORA | BUCCAL | 400 MCG | ||
| FENTORA | BUCCAL | 600 MCG | ||
| FENTORA | BUCCAL | 800 MCG | ||
| ACTIQ | LOZENGE | 200 MCG | ||
| ACTIQ | LOZENGE | 400 MCG | ||
| ACTIQ | LOZENGE | 600 MCG | ||
| ACTIQ | LOZENGE | 800 MCG | ||
| LAZANDA | NASAL SPRAY | 100 mcg | ||
| LAZANDA | NASAL SPRAY | 400 mcg |
View Other Therapeutic Options: Opioid Agonists:
280808
High Alert Drug
Last updated: Nov. 23, 2022
- Do Not Crush Do not crush lozenge/lollipop - delivery system requires slow dissolution in mouth. Buccal tablets are to be swallowed whole.
- Black Box Warning: Buccal tablets, nasal spray, and lozenges are only for management of breakthrough pain in opioid-tolerant patients.
Class II
ISMP recommended Tall Man Letters: fentaNYL. Double-checks for appropriateness of drug/dose/pump setting/line placement must be performed during PCA/Epidural use. See guidelines for conversion from opiates to Duragesic patches.
Pediatric Intranasal Fentanyl
The High Risk/High Alert Medication Policy may be found by using the search function in Policies and Procedures.